Union Health Ministry introduces Daily Drug Regimen for treatment of Tuberculosis

Nov 18, 2017 09:59 IST

The Union Ministry of Health and  Family Welfare on 17 November 2017 launched Daily Drug Regimen for treatment of Tuberculosis (TB) across the country under The Revised National TB Control Programme (RNTCP).

Earlier, the Health Ministry was providing the treatment of tuberculosis thrice weekly, however it has now decided to change the treatment strategy for TB patients from thrice weekly to daily drug regimen using fixed dose combinations (FDC) for treatment.

The move is aimed at bringing the transformation in the approach and the intensity to deal with this disease which accounts for about 4.2 lakh deaths every year.

CA eBook

Key Highlights
• The daily FDC anti-TB drugs will be made available to private pharmacy or at private practitioners to dispense to TB patients who seek care in private sector, depending upon the convenience of patient.
• The Health Ministry will also make anti-TB drugs available to all major hospitals, IMA, IAP and other professional medical associations to expand the access to daily FDC to all TB patients.
• Under this treatment strategy, Ethambutol will be given in continuation for all patients on daily basis along with fixed dose combination (FDC) tablets to reduce the pill burden (as against separate 7 tablets previously) for children.

As per WHO Global TB Report 2017, the incidence of TB has reduced from 28.2 lakh to 27 lakh over the last one year, which is a testimony of anti TB drive by Union Government.

Is this article important for exams ? Yes4 People Agreed
Read more Current Affairs on: Union Health Ministry , Daily Drug Regimen , Tuberculosis , TB

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK